benfluorex Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Benfluorex, sold under the brand name Mediator, is an anorectic and hypolipidemic agent that is structurally related to fenfluramine. It may improve glycemic control and decrease insulin resistance in people with poorly controlled type-2 diabetes.   Wikipedia

Chemistry

  • SMILES: CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2
  • InChIKey: CJAVTWRYCDNHSM-UHFFFAOYSA-N
  • Mol. Mass: 351.37
  • ALogP: 4.08
  • ChEMBL Molecules:
    benfluorex  
    benfluorex hydrochloride  
More Chemistry

Pharmacology

Alternative names

1-(2-trifluoromethylphenyl)-2-(benzoyloxyethyl)aminopropane hcl | 780 se | benfluorex | benfluorex hydrochloride | benfluorex hydrochloride, (+-)-isomer | benfluorex maleate | benfluorex methanesulfonate | benfluorex, methanesulfonate salt | benfluorexum | benfluramate | jp 992 | n-(2-benzoyloxyethyl)norfenfluramine | s 780 | se 780

Organizations (7)

Research & Development (7)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Diabetes Mellitus, Type 2 (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial Organizations: 7

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue